- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 405/00 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patent holdings for IPC class C07D 405/00
Total number of patents in this class: 239
10-year publication summary
|
9
|
4
|
5
|
5
|
6
|
5
|
4
|
4
|
7
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1624 |
12 |
| Merck Sharp & Dohme LLC | 3751 |
11 |
| Bayer Cropscience AG | 1957 |
7 |
| Theravance Biopharma R&D IP, LLC | 442 |
6 |
| Merck Sharp & Dohme Corp. | 2186 |
4 |
| Janssen Pharmaceutica N.V. | 3340 |
4 |
| Bristol-myers Squibb Company | 4795 |
3 |
| Hoffmann-La Roche Inc. | 3602 |
3 |
| Boehringer Ingelheim International GmbH | 4595 |
3 |
| Allergan, Inc. | 2282 |
3 |
| Amgen Inc. | 4290 |
3 |
| Dow AgroSciences LLC | 1210 |
3 |
| Corteva Agriscience LLC | 2663 |
3 |
| The Regents of the University of California | 20355 |
2 |
| Merck Patent GmbH | 5727 |
2 |
| Syngenta Participations AG | 1647 |
2 |
| Abbvie Inc. | 1820 |
2 |
| AB Pharma Ltd. | 14 |
2 |
| Biocon Limited | 223 |
2 |
| ChemoCentryx, Inc. | 372 |
2 |
| Other owners | 160 |